Literature DB >> 16269177

Multidrug-resistant Escherichia coli clonal groups causing community-acquired bloodstream infections.

Amee R Manges1, Françoise Perdreau-Remington, Owen Solberg, Lee W Riley.   

Abstract

OBJECTIVES: A multidrug-resistant Escherichia coli clonal group (designated CgA) has been isolated from women with cystitis and pyelonephritis in several communities. This study was designed to determine if CgA can cause community-acquired bloodstream infections.
METHODS: All community-acquired bloodstream infections caused by E. coli identified at the San Francisco General Hospital between May 2001 and May 2003 were included. The diagnosis of septicemia was based on admission diagnosis. E. coli isolates were characterized by antibiotic susceptibility profile, enterobacterial repetitive intergenic consensus (ERIC2) PCR, serogrouping, and pulsed field gel electrophoresis (PFGE).
RESULTS: A total of 127 individuals with a community-acquired bloodstream infection were identified; 48 (39%) were trimethoprim-sulfamethoxazole (SXT)-resistant. CgA, as defined by ERIC2 PCR, was responsible for 19 (15%) of these infections. Infection with a CgA isolate was associated with an admission diagnosis of cystitis or pyelonephritis (p=0.01). By PFGE, none of the CgA isolates were indistinguishable to the prototype cystitis strain; however, nine bloodstream isolates differed by fewer than six bands.
CONCLUSIONS: CgA can cause community-acquired bloodstream infections, but does not appear to cause a disproportionate number of severe extraintestinal infections. This study provides evidence that UTI-causing clonal groups can cause a wide spectrum of disease and are an important clinical and public health concern.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269177     DOI: 10.1016/j.jinf.2005.09.012

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  7 in total

1.  Rapid and Specific Detection of the Escherichia coli Sequence Type 648 Complex within Phylogroup F.

Authors:  James R Johnson; Brian D Johnston; David M Gordon
Journal:  J Clin Microbiol       Date:  2017-01-18       Impact factor: 5.948

2.  Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis.

Authors:  Frédéric Bert; James R Johnson; Bénédicte Ouattara; Véronique Leflon-Guibout; Brian Johnston; Estelle Marcon; Dominique Valla; Richard Moreau; Marie-Hélène Nicolas-Chanoine
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

3.  Enteroaggregative Escherichia coli related to uropathogenic clonal group A.

Authors:  Faith Wallace-Gadsden; James R Johnson; John Wain; Iruka N Okeke
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

4.  Pyelonephritis in Pediatric Uropathic Patients: Differences from Community-Acquired Ones and Therapeutic Protocol Considerations. A 10-Year Single-Center Retrospective Study.

Authors:  Giovanni Parente; Tommaso Gargano; Stefania Pavia; Chiara Cordola; Marzia Vastano; Francesco Baccelli; Giulia Gallotta; Laura Bruni; Adelaide Corvaglia; Mario Lima
Journal:  Children (Basel)       Date:  2021-05-23

5.  Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections.

Authors:  Amee R Manges; Helen Tabor; Patricia Tellis; Caroline Vincent; Pierre-Paul Tellier
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

6.  Identification and characterization of OmpT-like proteases in uropathogenic Escherichia coli clinical isolates.

Authors:  Isabelle Desloges; James A Taylor; Jean-Mathieu Leclerc; John R Brannon; Andrea Portt; John D Spencer; Ken Dewar; Gregory T Marczynski; Amee Manges; Samantha Gruenheid; Hervé Le Moual; Jenny-Lee Thomassin
Journal:  Microbiologyopen       Date:  2019-09-08       Impact factor: 3.904

7.  Food reservoir for Escherichia coli causing urinary tract infections.

Authors:  Caroline Vincent; Patrick Boerlin; Danielle Daignault; Charles M Dozois; Lucie Dutil; Chrissi Galanakis; Richard J Reid-Smith; Pierre Paul Tellier; Patricia A Tellis; Kim Ziebell; Amee R Manges
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.